
    
      The maximum study duration per participant was to be 267 weeks (approximately 5 years) broken
      down as follows:

        -  screening up to a maximum of 1 week;

        -  treatment up to a maximum of 260 weeks;

        -  follow-up of 6 weeks after treatment discontinuation.
    
  